Source:http://linkedlifedata.com/resource/pubmed/id/16671479
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0003402,
umls-concept:C0013604,
umls-concept:C0017262,
umls-concept:C0034693,
umls-concept:C0034721,
umls-concept:C0037925,
umls-concept:C0087111,
umls-concept:C0087140,
umls-concept:C0185117,
umls-concept:C0205198,
umls-concept:C0234131,
umls-concept:C0599732,
umls-concept:C0599946,
umls-concept:C1522492,
umls-concept:C2911684
|
pubmed:dateCreated |
2006-5-4
|
pubmed:abstractText |
The neuroprotective efficacy of post-injury treatment with the antioxidant compound H-290/51 (10, 30, and 60 minutes after trauma) on immediate early gene expression (c-fos), blood-spinal cord barrier (BSCB) permeability, edema formation, and motor dysfunction was examined in a rat model of spinal cord injury (SCI). SCI was produced by a longitudinal incision into the right dorsal horn of the T10-11 segment under Equithesin anesthesia. Focal SCI in control rats resulted in profound up-regulation of c-fos expression, BSCB dysfunction, edema formation, and cell damage in the adjacent T9 and T12 segments at 5 hours. Pronounced motor dysfunction was present at this time as assessed using the Tarlov scale and the inclined plane test. Treatment with H-290/51 (50 mg/kg, p.o.) 10 and 30 minutes after SCI (but not after 60 minutes) markedly attenuated c-fos expression and motor dysfunction. In these groups, BSCB permeability, edema formation, and cell injuries were mildly but significantly reduced. These observations suggest that (i) antioxidants are capable of attenuating cellular and molecular events following trauma, and (ii) have the capacity to induce neuroprotection and improve motor function if administered during the early phase of SCI, a novel finding.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antioxidants,
http://linkedlifedata.com/resource/pubmed/chemical/H290-51,
http://linkedlifedata.com/resource/pubmed/chemical/Indoles,
http://linkedlifedata.com/resource/pubmed/chemical/Neuroprotective Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-fos
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0065-1419
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
96
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
322-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16671479-Animals,
pubmed-meshheading:16671479-Antioxidants,
pubmed-meshheading:16671479-Apoptosis,
pubmed-meshheading:16671479-Edema,
pubmed-meshheading:16671479-Indoles,
pubmed-meshheading:16671479-Male,
pubmed-meshheading:16671479-Neuroprotective Agents,
pubmed-meshheading:16671479-Paraplegia,
pubmed-meshheading:16671479-Permeability,
pubmed-meshheading:16671479-Proto-Oncogene Proteins c-fos,
pubmed-meshheading:16671479-Rats,
pubmed-meshheading:16671479-Rats, Sprague-Dawley,
pubmed-meshheading:16671479-Spinal Cord Injuries,
pubmed-meshheading:16671479-Treatment Outcome
|
pubmed:year |
2006
|
pubmed:articleTitle |
Post-injury treatment with a new antioxidant compound H-290/51 attenuates spinal cord trauma-induced c-fos expression, motor dysfunction, edema formation, and cell injury in the rat.
|
pubmed:affiliation |
Laboratory of Cerebrovascular Research, Department of Surgical Sciences, Anesthesiology and Intensive Care Medicine, University Hospital, Uppsala University, Uppsala, Sweden. Sharma@surgsci.uu.se
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|